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Abstract
Background: Insulin resistance (IR) plays a major role in the pathogenesis of metabolic syndrome. Acanthosis
nigricans (AN) is an easily detectable skin condition that is strongly associated with IR. The aims of this study were,
firstly, to investigate the prevalence of AN among adults in an urban Sri Lankan community and secondly, to
describe its utility to detect metabolic syndrome.
Findings: In a community based investigation, 35-64 year adults who were selected using stratified random
sampling, underwent interview, clinical examination, liver ultrasound scanning, and biochemical and serological
tests. Metabolic syndrome was diagnosed on revised ATP III criteria for Asian populations. AN was identified by the
presence of dark, thick, velvety skin in the neck.
2957 subjects were included in this analysis. The prevalence of AN, metabolic syndrome and type 2 diabetes
mellitus were 17.4%, 34.8% and 19.6%, respectively. There was a strong association between AN and metabolic
syndrome. The sensitivity, specificity, positive predictive value and negative predictive value of AN to detect
metabolic syndrome were 28.2%, 89.0%, 45.9% and 79.0% for males, and 29.2%, 88.4%, 65.6% and 62.3% for
females, respectively.
Conclusions: AN was common in our study population, and although it did not have a high enough sensitivity to
be utilized as a screening test for metabolic syndrome, the presence of AN strongly predicts metabolic syndrome.
Background
Acanthosis nigricans (AN) is an easily identifiable skin
lesion characterized by velvety, brownish-black pigmen-
tation of the skin of the neck and intertriginous sur-
faces. Typical areas of involvement include the posterior
aspect of the neck, axillae, elbows and knees; the neck is
involved 93% to 99% of the time [1,2]. The common
occurrence of AN in the neck is important in a primary
care setting because it makes the lesion easily detectable.
A quantitative scale of AN has been developed by Burke
et al [1]. This scale takes into consideration the severity
of AN in neck and axilla, neck texture, and the presence
or absence of AN in knuckles, elbows and knees.
A number of studies have shown an association
between AN and insulin resistance [3,4] and the recent
increase in the prevalence of AN [5-7] may well reflect
increasing trends in obesity and type 2 diabetes world-
wide [1]. The prevalence of AN varies from 7% in unse-
lected populations to 74% in obese people [5,6]. It has
been shown to be a reliable cutaneous marker of insulin
resistance in obese Japanese children [8]. The prevalence
also varies in different racial groups. For example, Afri-
can Americans are 25 times more likely to have AN
than patients of European descent [2]. A study from the
USA reports that the prevalence of AN was 3% among
Caucasians, 19% in Hispanics and 28% in American
Indians [7]. Although obesity increases the risk of AN,
racial differences in the prevalence of AN cannot solely
be explained by different rates of obesity. Although a
hospital based study from India has reported a preva-
lence of AN of 65% among diabetics and 40% among
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our knowledge there are no data on community preva-
lence of AN from the Indian subcontinent.
The diagnosis of metabolic syndrome involves a bat-
tery of investigations that poses a challenge to doctors
working in poor countries, particularly in a primary care
s e t t i n g .I nt h e s es i t u a t i o n s ,w h e r et h e r ea r em a n yc o m -
peting demands within the brief patient encounter, a
clinical marker to rapidly identify persons at high risk
for metabolic syndrome would be very useful. AN may
be a suitable clinical marker especially in communities
where it is prevalent.
The aims of this study were, firstly to investigate the
prevalence of AN in an urban Sri Lankan community,
and secondly, to describe its utility to detect metabolic
syndrome.
Materials and methods
This study was part of a community based investigation -
the Ragama Health Study (RHS), conducted in the Ragama
Medical Officer of Health area [10]. This area has charac-
teristics typical of an urban community in Sri Lanka. Parti-
cipants were a representative sample of 35-64 year old
adults selected by stratified random sampling from elec-
toral lists. Ethical approval for the study was obtained
from the Ethics Review Committee of the Faculty of Medi-
cine University of Kelaniya. The purpose of the study, the
procedures to be carried out with potential hazards and
benefits were explained to the individuals prior to obtain-
ing informed written consent. Consenting adults were
screened by a structured interview, clinical examination,
liver ultrasound (8 MHz probe, Toshiba ultrasound diag-
nostic systems SSA-51 OA, Toshiba Medical Systems Cor-
poration, Otawara-city, Tochigi-prefecture, Japan) and
collection of 10 ml venous blood for biochemical tests.
Metabolic syndrome was diagnosed on revised ATP III
criteria for Asian populations [11]. AN was identified by
the presence of dark, thick, velvety, pigmented skin in the
neck (Figure 1). The person appearing in the photograph
(Mr KDEPN) has given informed written consent for it to
be published.
Statistical analysis
Data were entered in Epi Info 2000 (Centres for Disease
Control and Prevention, Atlanta. GA) and logical and
random checks were done. Statistical analysis was done
using SPSS version 16.0 (SPSS Inc., Chicago, IL). Con-
tinuous and categorical data were described using mean
and standard deviations. Significance testing was done
using the Student T test, Chi squared test and multiple
logistic regression. p < 0.05 was considered as signifi-
cant. The sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) of AN to
detect metabolic syndrome were calculated.
Results
3012 subjects participated in the study and 2957 had
information on the presence or absence of AN (Table 1, 2).
515 (17.4%) had AN, and 1025 (34.8%) had metabolic syn-
drome diagnosed by revised ATP III criteria (Table 3, 4).
Prevalence of type 2 diabetes mellitus was 18.9% among
males and 20.1% among females giving an overall preva-
lence of 19.6% (n = 584). There were 692 females (67.5%)
with metabolic syndrome (OR = 2.29; 95% CI: 1.96-2.69).
Age distribution between sexes was similar [males: mean
52.4 years (SD = 7.9) vs. females: mean 52.4 years (SD
7.8)]. AN was more common among both males [28.2% vs.
11.0% (OR = 3.18; 95% CI: 2.34-4.34)]; and females [29.2%
vs. 11.6% (OR = 3.15; 95% CI: 2.43-4.08)} with metabolic
syndrome. The sensitivity, specificity, PPV and NPV of AN
to detect metabolic syndrome were 28.2%, 89.0%, 45.9%,
and 79.0% for males, and 29.2%, 88.4%, 65.6% and 62.3%
for females, respectively.
Discussion
T h ep r e v a l e n c eo fA Ni nt h i su r b a na d u l tp o p u l a t i o n
from Sri Lanka was a relatively high 17.4%. To our
knowledge, this is the first community based prevalence
study of AN from the Indian subcontinent. Our results
a r ec o m p a r a b l ew i t hp r e v a l e n c ed a t ai nA m e r i c a n
Figure 1 A patient with acanthosis nigricans from the study.
Table 1 Demographic and anthropometric variables of
subjects with and without AN
Variable Subjects with
AN
Subjects without
AN
p
value
Males [Number
(%)]
206 (40) 1138 (47) 0.006
Age [Mean (SD)] 50.8 (7.6) 52.8 (7.8) < 0.001
BMI [Mean (SD)] 27.9 (4.0) 23.3 (3.9) < 0.001
Waist [Mean (SD)] 93.9 (9.1) 83.9 (10.2) < 0.001
Hip [Mean (SD)] 97.5 (8.3) 89.9 (8.0) < 0.001
WHR 0.96 (0.07) 0.93 (0.07) < 0.001
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we found that AN was significantly more common in
people with metabolic syndrome. We also found that
AN had a high specificity and NPV, but a low sensitivity
to detect metabolic syndrome. One of the shortcomings
in our study was that we did not quantify AN using a
standard scale, and only its presence or absence in the
neck was noted. However, we feel that if AN is to be a
useful clinical marker in primary care, its detection
would be most likely in an exposed area of skin.
Patients with AN are at risk for all components of the
metabolic syndrome, such as, obesity, hypertension, ele-
vated triglycerides, low HDL, and impaired glucose tol-
erance [12,13]. AN is also highly prevalent in certain
ethnic groups [5], and in such populations the easy
detectability increases its potential to play a bigger role
in detecting people at risk of metabolic syndrome. This
would be relevant to many developing countries with
poor resources, such as those in South Asia, which are
battling rapid increases in diabetes, obesity and other
components of the metabolic syndrome. Despite this,
there are few studies investigating the role of AN as a
clinical marker to detect people who are at risk of
having metabolic syndrome. In a recent study in the
USA, 49% of 676 fifth grade children with AN fulfilled
criteria for metabolic syndrome [14]. Some states in the
USA have encouraged their doctors to look for AN in
children in order to detect those at high risk of develop-
ing diabetes mellitus [15]. Several recent studies recom-
mend the use of AN as a marker of insulin resistance in
American Indian children [16].
Although AN was common in our study population,
its low sensitivity does not make it a suitable screening
test to detect metabolic syndrome. However, the high
specificity and NPV make AN a very useful sign to pre-
dict its presence. Primary health care workers and doc-
tors in resource poor settings should be trained to look
for and identify AN, and to refer those with the lesion
for further investigation and assessment of insulin resis-
tance and metabolic syndrome.
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Table 2 Demographic and anthropometric factors in subjects with and without metabolic syndrome and acanthosis
nigricans
Variable Acanthosis nigricans (subjects with metabolic syndrome
n = 1025)
Acanthosis nigricans (subjects without metabolic syndrome
n = 1924)
Present Absent p value Present Absent p value
n = 296 (28.9) n = 729 (71.1) n = 217 (11.3) n = 1707 (88.7)
Age 51.8 (7.4) 54.6 (7.0) < 0.001 49.4 (7.8) 52.0 (8.0) < 0.001
Males 94 (31.8) 239 (33.0) 0.71 111 (51.2) 899 (52.5) 0.72
BMI 28.4 (4.0) 25.5 (3.4) < 0.001 27.2 (3.8) 22.4 (3.8) < 0.001
Waist 95.3 (8.5) 90.3 (8.6) < 0.001 92.0 (9.4) 81.2 (9.6) < 0.001
WHR 0.97 (0.07) 0.96 (0.07) < 0.001 0.96 (0.07) 0.92 (0.07) 0.02
Table 3 Association of Acanthosis Nigricans with revised
ATP III criteria for diagnosis of metabolic syndrome in
Asians (based on bivariate analysis)
Criterion Odds
Ratio
95%
Confidence
limits
P value
Abdominal obesity 5.64 4.41-7.22 <0.001
(Waist circumference)
Males > 90 cm
Females > 80 cm
Triglycerides ≥150 mg/dl 1.81 1.49-2.20 <0.001
High-density lipoprotein cholesterol 1.56 1.25-1.94 <0.001
Males < 40 mg/dl
Females < 50 mg/dl
Blood pressure ≥130/≥85 mm Hg 2.04 1.66-2.51 <0.001
Fasting glucose > 110 mg/dl 1.85 1.53-2.25 <0.001
Table 4 Association of Acanthosis Nigricans with revised
ATP III criteria for diagnosis of metabolic syndrome in
Asians (based on multiple logistic regression)
Criterion b Odds
Ratio
Exp (b)
95%
Confidence
limits
P value
Abdominal obesity 1.553 4.72 3.67-6.07 < 0.001
(Waist circumference)
Males > 90 cm
Females > 80 cm
Triglycerides ≥150 mg/dl 0.347’ 1.42 1.15-1.75 0.001
High-density lipoprotein
cholesterol
0.274 1.32 1.05-1.66 0.020
Males < 40 mg/dl
Females < 50 mg/dl
Blood pressure ≥130/
≥85 mm Hg
0.394 1.48 1.19-1.85 0.001
Fasting glucose >
110 mg/dl
0.356 1.43 1.16-1.75 0.001
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